North America Syringe Infusion Pumps Market Size, Share & Trends Analysis Report By Disease Indication (Pediatrics/neonatology, Chemotherapy, Diabetes, Gastroenterology), By End Use (Hospitals, Homecare), By Country, And Segment Forecasts, 2025 - 2030

May 2025 | 80 pages | ID: NF9DCC21E030EN
Grand View Research, Inc.

Abstracts

This report can be delivered to the clients within 2 Business Days

North America Syringe Infusion Pumps Market Growth and Trends

The North America syringe infusion pumps market size is anticipated to reach USD 1.04 billion by 2030 and is expected to grow at a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing substantial growth driven by the increasing prevalence of chronic diseases, affecting approximately six in ten adults and necessitating precise, continuous medication delivery for conditions such as cancer and diabetes.

The rising number of surgical procedures and ICU admissions further amplifies demand for these pumps, crucial for delivering anesthetics and critical care medications. This is especially true considering the projected increase in U.S. hospitalizations from 36 million in 2025 to 40 million by 2035.

Technological advancements in smart infusion technologies, including Dose Error Reduction Systems (DERS) and EHR compatibility, are pivotal in enhancing medication safety and efficiency, as North America leads in their adoption. The expanding home healthcare and ambulatory care sectors, fueled by an aging population and cost-containment strategies, are increasing the demand for portable, user-friendly syringe pumps for safe medication delivery outside hospitals. Favorable regulatory environments and reimbursement policies further support the sustained growth and innovation within the market.

North America Syringe Infusion Pumps Market Report Highlights:

• Pediatrics/neonatology held the largest revenue share of over 25.0% in 2024, owing to the critical need for precise drug delivery for newborns and infants, coupled with advancements in safety technologies and NICU/PICU investments
• The chemotherapy segment is projected to grow at the fastest CAGR over the forecast period
• Market growth is fueled by the critical need for precise syringe pump delivery of potent drugs, supported by safety features, and the increasing number of cancer cases.
• Hospitals dominated the market with around 40.0% of the total revenue share in 2024 due to high demand for precise drug delivery in critical care and diverse applications.
• Homecare is projected to grow at the fastest CAGR of 8.7% over the forecast period.
• The U.S. dominated the North American syringe infusion pumps market, supported by the high prevalence of chronic diseases and growing national healthcare expenditure.

Companies Mentioned

Baxter
B. Braun Medical Inc.
Fresenius Kabi AG
ICU Medical, Inc.
Micrel Medical Devices SA
Boston Scientific Corporation
BD
Terumo Corporation
Moog Inc.
IRadimed Corporation
CODAN Companies
ACROMED

Contents

CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation & Scope
1.2. Segment Definitions
  1.2.1. Disease Indication
  1.2.2. End Use
  1.2.3. Country scope
  1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
  1.4.1. Purchased database
  1.4.2. GVR’s internal database
  1.4.3. Secondary sources
  1.4.4. Primary research
  1.4.5. Details of primary research
1.5. Information or Data Analysis
  1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Outlook
2.2. Segment Outlook
  2.2.1. Disease indication outlook
  2.2.2. End use outlook
  2.2.3. Country outlook
2.3. Competitive Insights

CHAPTER 3. NORTH AMERICA SYRINGE INFUSION PUMPS MARKET VARIABLES, TRENDS & SCOPE

3.1. Market Lineage Outlook
  3.1.1. Parent market outlook
  3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
  3.2.1. Market driver analysis
  3.2.2. Market restraint analysis
3.3. North America Syringe Infusion Pumps Market Analysis Tools
  3.3.1. Industry Analysis - Porter’s
    3.3.1.1. Supplier power
    3.3.1.2. Buyer power
    3.3.1.3. Substitution threat
    3.3.1.4. Threat of new entrant
    3.3.1.5. Competitive rivalry
  3.3.2. PESTEL Analysis
    3.3.2.1. Political landscape
    3.3.2.2. Technological landscape
    3.3.2.3. Economic landscape

CHAPTER 4. NORTH AMERICA SYRINGE INFUSION PUMPS MARKET: DISEASE INDICATION ESTIMATES & TREND ANALYSIS

4.1. Disease Indication Segment Dashboard
4.2. North America Syringe Infusion Pumps Market: Disease Indication Movement Analysis
4.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
4.4. Chemotherapy
  4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Diabetes
  4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Gastroenterology
  4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Analgesia/Pain Management
  4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Pediatrics/Neonatology
  4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Hematology
  4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Others
  4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)

CHAPTER 5. NORTH AMERICA SYRINGE INFUSION PUMPS MARKET: END USE ESTIMATES & TREND ANALYSIS

5.1. End Use Segment Dashboard
5.2. North America Syringe Infusion Pumps Market: End Use Movement Analysis
5.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
  5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Homecare
  5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Others (ASC, Nursing Homes, Rehabilitation Centers)
  5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

CHAPTER 6. NORTH AMERICA SYRINGE INFUSION PUMPS MARKET: COUNTRY ESTIMATES & TREND ANALYSIS

6.1. Country Market Dashboard
6.2. Country Market Share Analysis, 2024 & 2030
6.3. North America Syringe Infusion Pumps Market by country: Key Takeaways
6.4. U.S.
  6.4.1. Key country dynamics
  6.4.2. Regulatory framework/ reimbursement structure
  6.4.3. Competitive scenario
  6.4.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Canada
  6.5.1. Key country dynamics
  6.5.2. Regulatory framework/ reimbursement structure
  6.5.3. Competitive scenario
  6.5.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Mexico
  6.6.1. Key country dynamics
  6.6.2. Regulatory framework/ reimbursement structure
  6.6.3. Competitive scenario
  6.6.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

CHAPTER 7. COMPETITIVE LANDSCAPE

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
  7.3.1. Key company heat map analysis, 2024
7.4. Company Profiles
  7.4.1. Baxter
    7.4.1.1. Company overview
    7.4.1.2. Financial performance
    7.4.1.3. Product benchmarking
    7.4.1.4. Strategic initiatives
  7.4.2. B. Braun Medical Inc.
    7.4.2.1. Company overview
    7.4.2.2. Financial performance
    7.4.2.3. Product benchmarking
    7.4.2.4. Strategic initiatives
  7.4.3. Fresenius Kabi AG
    7.4.3.1. Company overview
    7.4.3.2. Financial performance
    7.4.3.3. Product benchmarking
    7.4.3.4. Strategic initiatives
  7.4.4. ICU Medical, Inc.
    7.4.4.1. Company overview
    7.4.4.2. Financial performance
    7.4.4.3. Product benchmarking
    7.4.4.4. Strategic initiatives
  7.4.5. Micrel Medical Devices SA
    7.4.5.1. Company overview
    7.4.5.2. Financial performance
    7.4.5.3. Product benchmarking
    7.4.5.4. Strategic initiatives
  7.4.6. Boston Scientific Corporation
    7.4.6.1. Company overview
    7.4.6.2. Financial performance
    7.4.6.3. Product benchmarking
    7.4.6.4. Strategic initiatives
  7.4.7. BD
    7.4.7.1. Company overview
    7.4.7.2. Financial performance
    7.4.7.3. Product benchmarking
    7.4.7.4. Strategic initiatives
  7.4.8. Terumo Corporation
    7.4.8.1. Company overview
    7.4.8.2. Financial performance
    7.4.8.3. Product benchmarking
    7.4.8.4. Strategic initiatives
  7.4.9. Moog Inc.
    7.4.9.1. Company overview
    7.4.9.2. Financial performance
    7.4.9.3. Product benchmarking
    7.4.9.4. Strategic initiatives
  7.4.10. IRadimed Corporation
    7.4.10.1. Company overview
    7.4.10.2. Financial performance
    7.4.10.3. Product benchmarking
    7.4.10.4. Strategic initiatives
  7.4.11. CODAN Companies
    7.4.11.1. Company overview
    7.4.11.2. Financial performance
    7.4.11.3. Product benchmarking
    7.4.11.4. Strategic initiatives
  7.4.12. ACROMED
    7.4.12.1. Company overview
    7.4.12.2. Financial performance
    7.4.12.3. Product benchmarking
    7.4.12.4. Strategic initiatives

List Of Tables

LIST OF TABLES

Table 1 List of abbreviations
Table 2 North America syringe infusion pumps market, by country, 2018 - 2030 (USD Million)
Table 3 North America syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 4 North America syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 5 U.S. syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 6 U.S. syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 7 Canada syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 8 Canada syringe infusion pumps market, by end use, 2018 - 2030 (USD Million)
Table 9 Mexico syringe infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 10 Mexico surgical ablation market, by end use, 2018 - 2030 (USD Million)

List Of Figures

LIST OF FIGURES

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 North America syringe infusion pumps market: market outlook
Fig. 10 North America syringe infusion pumps competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 North America syringe infusion pumps market driver impact
Fig. 16 North America syringe infusion pumps market restraint impact
Fig. 17 North America syringe infusion pumps market strategic initiatives analysis
Fig. 18 North America syringe infusion pumps market: Disease indication movement analysis
Fig. 19 North America syringe infusion pumps market: Disease indication outlook and key takeaways
Fig. 20 Chemotherapy estimates and forecast, 2018 - 2030
Fig. 21 Diabetes estimates and forecast, 2018 - 2030
Fig. 22 Gastroenterology estimates and forecast, 2018 - 2030
Fig. 23 Analgesia/Pain management estimates and forecast, 2018 - 2030
Fig. 24 Pediatrics/Neonatology estimates and forecast, 2018 - 2030
Fig. 25 Hematology estimates and forecast, 2018 - 2030
Fig. 26 Others estimates and forecast, 2018 - 2030
Fig. 27 North America syringe infusion pumps market: End use movement analysis
Fig. 28 North America syringe infusion pumps market: End use outlook and key takeaways
Fig. 29 Hospitals estimates and forecast, 2018 - 2030
Fig. 30 Homecare estimates and forecast, 2018 - 2030
Fig. 31 Others (ASC, nursing homes, rehabilitation centers) estimates and forecast, 2018 - 2030
Fig. 32 North America syringe infusion pumps market: Country movement analysis
Fig. 33 North America syringe infusion pumps market: Country outlook and key takeaways
Fig. 34 U.S. market estimates and forecasts, 2018 - 2030
Fig. 35 Canada market estimates and forecasts, 2018 - 2030
Fig. 36 Mexico market estimates and forecasts, 2018 - 2030